CELEX ONCOLOGY INNOVATIONS LIMITED
8 years
Company Age
Active
Status
21100
Industry
London
Location
79
days
Accounts Due
31 Dec 2026
169
days
CT600 Due
31 Mar 2027
Key Dates
Last Accounts Filed
31 December 2024
Financial Year End
31 December 2025
Accounts Due
79 days
31 December 2026
CT600 Due
169 days
31 March 2027
Confirmation Statement
188 days
19 April 2027
Financial Snapshot 2024
Profit
£0
+100%
Net Assets
£2.3M
+190.2%
Cash
£1.6M
- Company Type
- Ltd
- Incorporated
- 28 November 2017
- Registered Address
- 101 New Cavendish Street, 1st Floor South, London, W1W 6XH
- SIC Codes
-
- 21100
Browse Similar Companies
Similar companies in London
Active companies with the same industry classification (SIC 21100).
- GYNOPHARMA LTD 10671755
- CORCEPT THERAPEUTICS UK LIMITED 10694542
- KEYBIOTECH LTD 10697194
- BONE GUARDIAN LIMITED 10808908
- WARK SERVICES LIMITED 11238074
- CELADON PHARMACEUTICALS LIMITED 11545912
- PHARMACARE SUPPLIES INTERNATIONAL LIMITED 11743101
- BLUEPRINT MEDICINES (UK) LTD. 12084232
When are CELEX ONCOLOGY INNOVATIONS LIMITED's accounts due?
CELEX ONCOLOGY INNOVATIONS LIMITED's next accounts are due by 31 December 2026 (79 days from now).
Is CELEX ONCOLOGY INNOVATIONS LIMITED still trading?
Yes, CELEX ONCOLOGY INNOVATIONS LIMITED is currently Active according to Companies House records.
What does CELEX ONCOLOGY INNOVATIONS LIMITED do?
CELEX ONCOLOGY INNOVATIONS LIMITED is classified as 21100.
How old is CELEX ONCOLOGY INNOVATIONS LIMITED?
CELEX ONCOLOGY INNOVATIONS LIMITED was incorporated on 28 November 2017 and is 8 years old.